Literature DB >> 9715875

5% Me2SO is sufficient to preserve stem cells derived from cord blood.

E Richter1, H Eichler, D Raske, A Leveringhaus, W Zieger, M Kerowgan, S F Goldmann.   

Abstract

On the basis of historical findings, 10% dimethylsulfoxide is still used to cryopreserve stem cells. We studied a final concentration of 5% dimethylsulfoxide in cryopreservation of cord blood-derived stem cells in autologous plasma. In our opinion, a final concentration of 5% dimethylsulfoxide in autologous plasma without further additives is sufficient for cryopreservation of cord blood stem cells in a banking routine.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9715875

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  4 in total

1.  Clinical grade adult stem cell banking.

Authors:  Sreedhar Thirumala; W Scott Goebel; Erik J Woods
Journal:  Organogenesis       Date:  2009-07       Impact factor: 2.500

Review 2.  Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Authors:  Z Shu; S Heimfeld; D Gao
Journal:  Bone Marrow Transplant       Date:  2013-09-30       Impact factor: 5.483

3.  Evaluation of methylcellulose and dimethyl sulfoxide as the cryoprotectants in a serum-free freezing media for cryopreservation of adipose-derived adult stem cells.

Authors:  Sreedhar Thirumala; Jeffrey M Gimble; Ram V Devireddy
Journal:  Stem Cells Dev       Date:  2010-04       Impact factor: 3.272

4.  Reversible femtosecond laser-assisted myopia correction: a non-human primate study of lenticule re-implantation after refractive lenticule extraction.

Authors:  Andri K Riau; Romesh I Angunawela; Shyam S Chaurasia; Wing S Lee; Donald T Tan; Jodhbir S Mehta
Journal:  PLoS One       Date:  2013-06-24       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.